Suppr超能文献

非酒精性脂肪性肝病肥胖男性和女性的脂肪组织及肝脏脂质动力学改变

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

作者信息

Fabbrini Elisa, Mohammed B Selma, Magkos Faidon, Korenblat Kevin M, Patterson Bruce W, Klein Samuel

机构信息

Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.

Abstract

BACKGROUND & AIMS: Steatosis in patients with nonalcoholic fatty liver disease (NAFLD) is due to an imbalance between intrahepatic triglyceride (IHTG) production and export. The purpose of this study was to evaluate TG metabolism in adipose tissue and liver in NAFLD.

METHODS

Fatty acid, VLDL-TG, and VLDL-apolipoprotein B-100 (apoB100) kinetics were assessed by using stable isotope tracers in 14 nondiabetic obese subjects with NAFLD (IHTG, 22.7% +/- 2.0%) and 14 nondiabetic obese subjects with normal IHTG content (IHTG, 3.4% +/- 0.4%), matched on age, sex, body mass index, and percent body fat.

RESULTS

Compared with the normal IHTG group, the NAFLD group had greater rates of palmitate release from adipose tissue into plasma (85.4 +/- 6.6 and 114.1 +/- 8.1 micromol/min, respectively; P = .01) and VLDL-TG secretion (11.4 +/- 1.1 and 24.3 +/- 3.1 micromol/min, respectively; P = .001); VLDL-apoB100 secretion rates were not different between groups. The increase in VLDL-TG secretion was primarily due to an increased contribution from "nonsystemic" fatty acids, presumably derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis. VLDL-TG secretion rate increased linearly with increasing IHTG content in subjects with normal IHTG but reached a plateau when IHTG content was >/=10% (r = 0.618, P < .001).

CONCLUSIONS

Obese persons with NAFLD have marked alterations in both adipose tissue (increased lipolytic rates) and hepatic (increased VLDL-TG secretion) TG metabolism. Fatty acids derived from nonsystemic sources are responsible for the increase in VLDL-TG secretion. However, the increase in hepatic TG export is not adequate to normalize IHTG content.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)患者的肝脂肪变性是由于肝内甘油三酯(IHTG)生成与输出之间的失衡所致。本研究旨在评估NAFLD患者脂肪组织和肝脏中的甘油三酯(TG)代谢情况。

方法

采用稳定同位素示踪剂,对14名非糖尿病肥胖NAFLD患者(IHTG,22.7%±2.0%)和14名IHTG含量正常的非糖尿病肥胖患者(IHTG,3.4%±0.4%)的脂肪酸、极低密度脂蛋白-TG(VLDL-TG)及极低密度脂蛋白载脂蛋白B-100(apoB100)动力学进行评估,两组在年龄、性别、体重指数及体脂百分比方面相匹配。

结果

与IHTG正常组相比,NAFLD组脂肪组织中棕榈酸释放至血浆的速率更高(分别为85.4±6.6和114.1±8.1μmol/min;P = 0.01),VLDL-TG分泌速率也更高(分别为11.4±1.1和24.3±3.1μmol/min;P = 0.001);两组间VLDL-apoB100分泌速率无差异。VLDL-TG分泌增加主要归因于“非系统性”脂肪酸贡献增加,推测这些脂肪酸源自肝内和腹内脂肪的脂解作用及从头脂肪生成。在IHTG正常的受试者中,VLDL-TG分泌速率随IHTG含量增加呈线性增加,但当IHTG含量≥10%时达到平台期(r = 0.618,P < 0.001)。

结论

患有NAFLD的肥胖者在脂肪组织(脂解速率增加)和肝脏(VLDL-TG分泌增加)的TG代谢方面均有显著改变。非系统性来源的脂肪酸导致了VLDL-TG分泌增加。然而,肝脏TG输出的增加不足以使IHTG含量恢复正常。

相似文献

1
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.
4
Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.
J Lipid Res. 2024 Jul;65(7):100580. doi: 10.1016/j.jlr.2024.100580. Epub 2024 Jun 18.
5
Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.
Gastroenterology. 2016 Jan;150(1):79-81.e2. doi: 10.1053/j.gastro.2015.09.003. Epub 2015 Sep 12.
6
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
Obesity (Silver Spring). 2009 Jan;17(1):25-9. doi: 10.1038/oby.2008.494. Epub 2008 Oct 23.
7
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5. doi: 10.1073/pnas.0904944106. Epub 2009 Aug 24.
9
Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity.
Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E549-56. doi: 10.1152/ajpendo.00379.2002. Epub 2002 Dec 10.
10
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Gastroenterology. 2008 May;134(5):1369-75. doi: 10.1053/j.gastro.2008.01.075. Epub 2008 Jan 30.

引用本文的文献

1
Thermoneutral housing worsens MASLD and reveals defective brown adipose tissue response to β3-adrenergic stimulation.
iScience. 2025 Jul 26;28(9):113221. doi: 10.1016/j.isci.2025.113221. eCollection 2025 Sep 19.
2
Skeletal Muscle and Cardiovascular Health.
Adv Exp Med Biol. 2025;1478:631-659. doi: 10.1007/978-3-031-88361-3_26.
4
The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Diabetes Metab Syndr Obes. 2025 Jul 23;18:2477-2491. doi: 10.2147/DMSO.S528569. eCollection 2025.
5
Some paradoxes and unresolved aspects of hepatic de novo lipogenesis.
NPJ Metab Health Dis. 2024 Aug 2;2(1):18. doi: 10.1038/s44324-024-00020-7.
7
Unraveling the Gut-Liver-Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches.
Mediators Inflamm. 2025 Jun 18;2025:6733477. doi: 10.1155/mi/6733477. eCollection 2025.
8
Geranylgeranyl Pyrophosphate Promotes Hepatic Lipid Accumulation by Prenylation of Perilipin4.
Cell Mol Gastroenterol Hepatol. 2025 May 29;19(9):101546. doi: 10.1016/j.jcmgh.2025.101546.
10
Weight loss in MASLD restores the balance of liver fatty acid sources.
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI174233.

本文引用的文献

1
Assessment of intrahepatic triglyceride content using magnetic resonance spectroscopy.
J Cardiometab Syndr. 2007 Spring;2(2):136-8. doi: 10.1111/j.1559-4564.2007.07168.x.
2
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1.
3
Fatty liver and the metabolic syndrome.
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
4
Women produce fewer but triglyceride-richer very low-density lipoproteins than men.
J Clin Endocrinol Metab. 2007 Apr;92(4):1311-8. doi: 10.1210/jc.2006-2215. Epub 2007 Jan 30.
5
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189.
6
CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice.
J Biol Chem. 2006 Oct 20;281(42):31713-9. doi: 10.1074/jbc.M603422200. Epub 2006 Aug 20.
7
8
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease.
Gastroenterology. 2006 Apr;130(4):1343-6. doi: 10.1053/j.gastro.2006.02.040.
9
Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia. 2006 Apr;49(4):755-65. doi: 10.1007/s00125-005-0125-z. Epub 2006 Feb 4.
10
Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men.
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E355-62. doi: 10.1152/ajpendo.00259.2005. Epub 2005 Oct 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验